No itraconazole treatment
2 capsules in the morning
2 capsules in the afternoon
Stop treatment
Foot nails with or without hand nail infection
2 capsules in the morning
2 capsules in the afternoon
No itraconazole treatment
2 capsules in the morning
2 capsules in the afternoon
No itraconazole treatment
2 capsules in the morning
2 capsules in the afternoon
Stop treatment
Your doctor may prescribe different doses for different periods, depending on your condition.It is essential to complete the entire treatment prescribed by your doctor..
What to expect from Itragerm treatment
Do not worry if you do not see an improvement immediately after treatment.
Consult your doctor or pharmacistif you are unsure if the treatment is working.
If you take more Itragerm than you should
Call the nearest hospital emergency service or your doctor immediately:
Take this leaflet, the remaining capsules, and the packaging with you to the hospital or doctor so they know which medication was ingested.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or the Toxicology Information Service, Teléfono 91 562 04 20, indicating the medication and the amount used.
If you forget to take Itragerm
If you forget to take a dose, take the next one as usual. Then, continue with the treatment until you have finished all the capsules.
Do not take a double dose to compensate for the missed doses.
If you interrupt Itragerm treatment
If you stop taking Itragerm before completing all the capsules, it is possible that the infection will not be fully treated and will recur.Do not stop treatment until you have finished it, even if you feel better..
Like all medicines, Itragermmay cause side effects, although not everyone will experience them.
If you consider that any of the side effects you are experiencing are severe or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.
Adverse reactions were classified by frequency using the following convention:
Infections and infestations
Uncommon: sinusitis (nasal sinus irritation and swelling), upper respiratory tract infection, rhinitis (inflammation of the nasal mucosa with watery discharge and frequent sneezing)
Blood and lymphatic system disorders
Rare: leucopenia
Immune system disorders
Uncommon: hypersensitivity and allergic reactions
Rare: anaphylactic reactions (allergic reactions), serum sickness (allergy that appears after the injection of some sera, characterized by the appearance of urticaria, fluid accumulation, joint pain, fever, and extreme exhaustion), angioneuritic edema (fluid accumulation that can affect the mouth and upper respiratory tract)
Metabolism and nutrition disorders
Rare: increased triglycerides
Nervous system disorders
Common: headache
Rare: tremor, numbness in the extremities (paresthesia), decreased sensitivity (hypoaesthesia), unpleasant taste (bad taste)
Eye disorders
Rare: visual disturbances (including blurred vision and double vision)
Ear and labyrinth disorders
Rare: permanent or temporary hearing loss, subjective sensation of ear noises
Cardiac disorders
Rare: congestive heart failure
Respiratory, thoracic and mediastinal disorders
Rare: dyspnea, shortness of breath
Gastrointestinal disorders
Common: abdominal pain, nausea
Uncommon: vomiting, meal-related discomfort, diarrhea, constipation, flatulence
Rare: pancreatitis
Hepatobiliary disorders:
Uncommon: abnormal liver function
Rare: elevated bilirubin levels in blood (hyperbilirubinemia), severe hepatotoxicity (including cases of acute severe liver failure)
Skin and subcutaneous tissue disorders
Uncommon: urticaria, rash, pruritus
Rare: toxic epidermal necrolysis (severe skin disease characterized by skin rash and the appearance of blisters and scales), Stevens-Johnson syndrome (severe skin, mucous membrane, and eye inflammation), a severe skin disorder (generalized rash with skin peeling and blisters in the mouth, eyes, and genitals, or generalized rash with small pustules or blisters), multiform erythema (skin disease characterized by the appearance of vesicles, blisters, etc.), exfoliative dermatitis (skin disease characterized by skin peeling), leukocytoclastic vasculitis (inflammation of the blood vessel walls), alopecia (hair loss), photosensitivity (exaggered skin response to sunlight)
Renal and urinary disorders
Rare: increased frequency of urination
Reproductive and breast disorders
Uncommon: menstrual disorders
Rare: erectile dysfunction
Investigations
Rare: increased creatine phosphokinase levels in blood (parameter that measures liver function)
Description of certain side effects
The following side effects have been reported in patients taking other formulations of conventional itraconazole (oral or intravenous solution)
-Blood and lymphatic system disorders: granulocytopenia, thrombocytopenia (decreased levels of certain blood cells)
-Immune system disorders: anaphylactoid reaction
-Metabolism and nutrition disorders: hyperglycemia (increased blood sugar levels), hyperkalemia (high potassium levels in blood), hypokalemia (low potassium levels in blood), hypomagnesemia (low magnesium levels in blood)
-Mental disorders: feeling of confusion or disorientation
-Nervous system disorders: peripheral neuropathy (affection of peripheral nerves with numbness, tingling, or weakness in the extremities), dizziness, somnolence
-Cardiac disorders: heart failure, left ventricular insufficiency, tachycardia (rapid heart rate)
-Vascular disorders: hypertension (high blood pressure), hypotension (low blood pressure)
-Respiratory, thoracic and mediastinal disorders: pulmonary edema, cough, dyspnea
-Gastrointestinal disorders: gastrointestinal disorder
-Hepatobiliary disorders: liver insufficiency, hepatitis, jaundice (yellowing of the skin, eyes, mucous membranes, and secretions)
-Skin and subcutaneous tissue disorders: erythematous rash (red rash), excessive sweating
-Musculoskeletal and connective tissue disorders: muscle pain or weakness (myalgia), joint pain (arthralgia)
-Renal and urinary disorders: renal insufficiency, urinary incontinence (urine loss)
-General disorders and administration site conditions: generalized edema, facial edema, chest pain, fever, pain, fatigue, chills
-Investigations: increased alanine aminotransferase, increased aspartate aminotransferase, increased alkaline phosphatase in blood, increased lactate dehydrogenase in blood, increased urea in blood, increased gamma-glutamyltransferase, increased liver enzymes, abnormal urine analysis
If you experience any type of side effect, consult your doctor or pharmacist even if it is a possible side effect not mentioned in this leaflet. You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
.<
Keep Itragerm out of sight and reach of children.
Packaging Sizes
HDPE Bottles/Aluminum Semi-Rigid Blister:
This medication does not require any special storage temperature.
Store in the original packaging to protect it from light and moisture.
Triple Blister: Do not store above 25°C.
Store the capsules in the original packaging to protect them from light and moisture.
Do not use Itragerm after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or trash. Dispose of the packaging and unused medicines at the SIGRE Point of the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.
Composition of Itragerm
The active ingredient is itraconazole.
Each hard capsule contains 50 mg of itraconazole.
The other components are hypromellose phthalate, sodium starch glycolate type A, anhydrous colloidal silica, magnesium stearate.
The capsule is made of gelatin and the colors are FD&C Blue FC (E133), titanium dioxide (E171).
The capsule is printed with black ink (SW-9008), formed by shellac, potassium hydroxide, iron oxide black (E172) and purified water.
Appearance of the Itragerm product and contents of the packaging
Itragerm 50 mg hard capsules are clear blue hard gelatin capsules (size 1) with i-50 printed in black ink.
Itragerm is available in blister pack sizes of 4, 6, 7, 8, 14, 15, 18, 28, 30 and 60 capsules.
Itragerm is available in bottle sizes of 15, 30, 60 and 90 capsules.
Marketing authorization holder and responsible manufacturer
ISDIN, S.A. Provençals, 33. 08019 Barcelona
Manufacturer
MEDICOFARMA, S.A.Tarnobrzeska 13Radom26-613Poland.
This medicinal product is authorized in the member states of the European Economic Area with the following names:
Germany: | ITRAISDIN |
Spain, Italy: | ITRAGERM |
Austria: | MYTRA |
This leaflet was approved in June 2024.
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.es/.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.